XERS Xeris Biopharma Holdings, Inc. - Common Stock
$6,10
Prezzo · Mag 20, 2026
Fondamentali al Mag 7, 2026
Intervallo 52 sett.
$4–$10
31% of range
Rating Analisti
BUY
13 analysts
Prezzo Obiettivo
$11
+85% upside
P/E (TTM)
—
ROE
-19.7%
Margine di Profitto Netto
0.19%
XERS Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$6.09
Capitalizzazione di Mercato
$1.30B
P/E (TTM)
—
EPS (TTM)
$0.00
Ricavi (TTM)
$292M
Rendimento div.
—
ROE
-19.7%
D/E Debito/Patrimonio
16.1
Intervallo 52 sett.
$4 – $10
XERS Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$292M
2020-12-31
→
2025-12-31
EPS
$0.00
2021-12-31
→
2025-12-31
Flusso di cassa libero
—
2021-12-31
→
2021-12-31
Margini
0.19%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
XERS
Mediana dei peer
P/S (TTM)
4.5
7.2
P/B
95.3
4.6
EV / EBITDA
54.0
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
XERS
Mediana dei peer
Operating Margin (Margine Operativo)
8.5%
—
Net Profit Margin (Margine di Profitto Netto)
0.19%
-3.9%
ROA
0.16%
-7.1%
ROE
-19.7%
-18.6%
ROIC
10.6%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
XERS
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
16.1
2560.2
Current Ratio (Rapporto corrente)
2.2
3.9
Quick Ratio
1.5
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
XERS
Mediana dei peer
Revenue YoY (Ricavi YoY)
43.7%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
38.3%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
70.2%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
XERS
Mediana dei peer
XERS Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
13 analisti
- Acquisto forte 5 38,5%
- Compra 6 46,2%
- Mantieni 2 15,4%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
7 analisti · 2026-05-19
Mediana
$10.00
Media
$11.29
← Sotto tutti i target
$6.09
Basso
$8.00
Alto
$18.00
Target mediano
$10.00
+64,1%
Target medio
$11.29
+85,2%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.01%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2026 | $0.01 | $-0.01 | 0.02% |
| 31 Dicembre 2025 | $0.06 | $0.04 | 0.02% |
| 30 Settembre 2025 | $0.00 | $0.00 | -0.00% |
| 30 Giugno 2025 | $-0.01 | $-0.03 | 0.02% |
| 31 Marzo 2025 | $-0.06 | $-0.05 | -0.01% |
Confronto tra pari Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| XERS | $1.30B | — | 43.7% | 0.19% | -19.7% | — |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | — |
| HROW | $1.82B | -350.0 | 36.4% | -1.9% | -8.4% | 75.0% |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | — |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | — |
| ETON | $457M | — | 104.9% | -5.8% | -18.4% | 53.5% |
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| OMER | $1.23B | -343.6 | — | — | 1.9% | — |
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 14
| Metrica | Tendenza | 2025 | 2024 | 2024 | 2023 | 2023 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $292M | $203M | · | $164M | · | · | $110M | $50M | $20M | |
| R&D Expense | $31M | $26M | · | $22M | · | · | $21M | $25M | $21M | |
| SG&A Expense | $182M | $163M | · | $146M | · | · | $138M | $126M | $74M | |
| Operating Income | $25M | $-34M | · | $-44M | · | · | $-82M | $-115M | $-84M | |
| Interest Expense | · | · | · | $27M | · | · | $14M | $7M | $11M | |
| Other Non-op | $-24M | $-23M | · | $-19M | · | · | $-14M | $-8M | $-8M | |
| Pretax Income | $554.0K | $-57M | · | $-64M | · | · | $-96M | $-123M | · | |
| Income Tax | $0 | $-2M | · | $-1M | · | · | $-1M | $0 | $-110.0K | |
| Net Income | $554.0K | $-55M | · | $-62M | · | · | $-95M | $-123M | $-91M | |
| EPS (Basic) | $0.00 | $-0.37 | · | $-0.45 | · | · | $-0.70 | $-1.55 | · | |
| EPS (Diluted) | $0.00 | $-0.37 | · | $-0.45 | · | · | $-0.70 | $-1.55 | · | |
| Shares (Basic) | 160,425,198 | 146,772,758 | · | 137,674,857 | · | · | 135,628,721 | 79,027,062 | · | |
| Shares (Diluted) | 172,742,720 | 146,772,758 | · | 137,674,857 | · | · | 135,628,721 | 79,027,062 | · | |
| EBITDA | $26M | $-32M | · | $-43M | · | · | $-81M | $-114M | · |
Stato Patrimoniale 29
| Metrica | Tendenza | 2025 | 2024 | 2024 | 2023 | 2023 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $72M | $63M | $67M | $46M | $51M | $122M | $67M | $38M | |
| Short-term Investments | · | $0 | $25M | $5M | $34M | $44M | $0 | $35M | $96M | |
| Receivables | $51M | $40M | $37M | $39M | $30M | $31M | $31M | $17M | $7M | |
| Inventory | $69M | $48M | $41M | $39M | $37M | $29M | $25M | $18M | $8M | |
| Prepaid Expense | $10M | $7M | $8M | $6M | $8M | $11M | $9M | $5M | $3M | |
| Current Assets | $240M | $168M | $173M | $156M | $156M | $166M | $187M | $143M | $152M | |
| PP&E (Net) | $5M | $6M | $6M | $6M | $7M | $6M | $6M | $7M | $7M | |
| PP&E (Gross) | $13M | $13M | $12M | $12M | $13M | $12M | $11M | $11M | $9M | |
| Accum. Depreciation | $8M | $7M | $6M | $6M | $6M | $6M | $6M | $4M | $3M | |
| Goodwill | $23M | $23M | $23M | $23M | $23M | $23M | $23M | $23M | $0 | |
| Intangibles | $88M | $99M | $107M | $110M | $115M | $118M | $121M | $131M | $0 | |
| Other Non-current Assets | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $829.0K | $232.0K | |
| Total Assets | $384M | $323M | $337M | $323M | $329M | $321M | $345M | $304M | $159M | |
| Accounts Payable | $3M | $2M | $7M | $12M | $12M | $12M | $5M | $9M | $3M | |
| Accrued Liabilities | $33M | $28M | $22M | $24M | $19M | $20M | $37M | $49M | $16M | |
| Current Liabilities | $110M | $100M | $73M | $95M | $80M | $81M | $74M | $79M | $28M | |
| Capital Leases | $32M | $33M | $34M | $35M | $35M | $9M | $9M | $0 | · | |
| Deferred Tax | · | $0 | $3M | $2M | $3M | $4M | $4M | $5M | $0 | |
| Other Non-current Liabilities | $8M | $2M | $6M | $5M | $3M | $31.0K | $31.0K | $2M | $4M | |
| Total Liabilities | $370M | $353M | $346M | $329M | $315M | $291M | $299M | $209M | $125M | |
| Long-term Debt | $220M | $232M | $230M | $191M | $188M | $188M | $187M | $88M | $87M | |
| Total Debt | $220M | $232M | · | · | · | · | · | · | · | |
| Common Stock | $17.0K | $15.0K | $15.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $6.0K | |
| Paid-in Capital | $685M | $642M | $627M | $610M | $605M | $602M | $600M | $555M | $371M | |
| Retained Earnings | $-671M | $-672M | $-636M | $-617M | $-591M | $-572M | $-555M | $-460M | $-337M | |
| AOCI | $-25.0K | $-25.0K | $-36.0K | $-25.0K | $-78.0K | $-29.0K | $-23.0K | $-31.0K | $6.0K | |
| Stockholders' Equity | $14M | $-30M | $-9M | $-7M | $14M | $30M | $45M | $95M | $34M | |
| Liabilities + Equity | $384M | $323M | $337M | $323M | $329M | $321M | $345M | $304M | $159M | |
| Shares Outstanding | 166,215,410 | 149,429,410 | 148,224,403 | 138,130,715 | 138,012,130 | 137,291,277 | 136,273,090 | 124,873,316 | 59,611,202 |
Flusso di cassa 15
| Metrica | Tendenza | 2025 | 2024 | 2024 | 2023 | 2023 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | · | $1M | · | · | $1M | $1M | $1M | |
| Stock-based Comp | $22M | $18M | · | $11M | · | · | $12M | $11M | $8M | |
| Deferred Tax | $0 | $-2M | · | $-1M | · | · | $-1M | $0 | · | |
| Amort. of Intangibles | $11M | $11M | · | $11M | · | · | $11M | $550.0K | $0 | |
| Other Non-cash | $4M | $533.0K | · | $4M | · | · | $-20M | $14M | · | |
| Operating Cash Flow | $29M | $-37M | · | $-47M | · | · | $-103M | $-96M | $-81M | |
| CapEx | · | · | · | · | · | · | · | $1M | $377.0K | |
| Investing Cash Flow | $-696.0K | $5M | · | $-6M | · | · | $34M | $98M | $-27M | |
| Debt Issued | · | $0 | · | $0 | · | · | $146M | $0 | $95M | |
| Net Debt Issued | · | $0 | · | $0 | · | · | $103M | $0 | · | |
| Stock Issued | · | $0 | · | $0 | · | · | $30M | $27M | $66M | |
| Net Stock Activity | · | $0 | · | $0 | · | · | $30M | $27M | · | |
| Financing Cash Flow | $11M | $36M | · | $-2M | · | · | $127M | $27M | $126M | |
| Net Change in Cash | $39M | $4M | · | $-55M | · | · | $59M | $30M | $18M | |
| Free Cash Flow | · | · | · | · | · | · | · | $-97M | · |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2024 | 2023 | 2023 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 8.5% | -16.6% | · | -26.9% | · | · | -74.3% | -232.2% | · | |
| Net Margin | 0.19% | -27.0% | · | -38.0% | · | · | -85.9% | -247.5% | · | |
| Pretax Margin | 0.19% | -28.1% | · | -38.7% | · | · | · | · | · | |
| EBITDA Margin | 9.0% | -16.0% | · | -25.9% | · | · | -73.0% | -229.5% | · | |
| ROA | 0.16% | -16.6% | · | -19.1% | · | · | -29.2% | -52.9% | · | |
| ROE | -19.7% | 189.3% | · | 4268.4% | · | · | -188.9% | -264.6% | · | |
| ROIC | 10.6% | -16.0% | · | 636.2% | · | · | · | · | · |
Liquidità e Solvibilità 5
| Metrica | Tendenza | 2025 | 2024 | 2024 | 2023 | 2023 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 1.7 | · | 1.6 | · | · | 2.5 | 1.8 | · | |
| Quick Ratio | 1.5 | 1.1 | · | 1.2 | · | · | 2.1 | 1.5 | · | |
| Debt / Equity | 16.1 | -7.8 | · | · | · | · | · | · | · | |
| LT Debt / Equity | 16.1 | -7.3 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | -1.7 | · | · | -5.3 | -16.0 | · |
Efficienza 2
| Metrica | Tendenza | 2025 | 2024 | 2024 | 2023 | 2023 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.6 | · | 0.5 | · | · | 0.3 | 0.2 | · | |
| Receivables Turnover | 6.4 | 5.2 | · | 4.7 | · | · | 4.6 | 4.1 | · |
Tassi di Crescita 3
| Metrica | Tendenza | 2025 | 2024 | 2024 | 2023 | 2023 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 43.7% | 23.9% | · | 48.7% | · | · | 122.3% | 142.7% | · | |
| Revenue CAGR 3Y | 38.3% | 60.0% | · | 100.2% | · | · | · | · | · | |
| Revenue CAGR 5Y | 70.2% | · | · | · | · | · | · | · | · |
Valutazione (TTM) 11
| Metrica | Tendenza | 2025 | 2024 | 2024 | 2023 | 2023 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $292M | $203M | · | $164M | · | · | $110M | $50M | · | |
| Net Income TTM | $554.0K | $-55M | · | $-62M | · | · | $-95M | $-123M | · | |
| Market Cap | $1.30B | $507M | · | $325M | · | · | $181M | · | · | |
| Enterprise Value | $1.41B | $667M | · | · | · | · | · | · | · | |
| P/E | · | -9.2 | · | -5.2 | · | · | -1.9 | -1.9 | · | |
| P/S | 4.5 | 2.5 | · | 2.0 | · | · | 1.6 | · | · | |
| P/B | 95.3 | -17.1 | · | -47.9 | · | · | 4.0 | · | · | |
| P / Cash Flow | 45.6 | -13.7 | · | -6.9 | · | · | -1.8 | · | · | |
| EV / EBITDA | 54.0 | -20.6 | · | · | · | · | · | · | · | |
| EV / Revenue | 4.8 | 3.3 | · | · | · | · | · | · | · | |
| Earnings Yield | 0.00% | -10.9% | · | -19.1% | · | · | -52.6% | -52.9% | · |
Conto Economico 13
| Metrica | Tendenza | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $83M | $86M | $74M | $72M | $60M | $60M | $54M | $48M | $41M | $44M | $48M | $38M | $33M | $33M | $30M | $25M | |
| R&D Expense | $9M | $8M | $7M | $8M | $8M | $6M | $6M | $6M | $8M | $6M | $5M | $6M | $5M | $5M | $6M | $4M | |
| SG&A Expense | $53M | $48M | $46M | $44M | $44M | $40M | $45M | $40M | $38M | $38M | $37M | $38M | $34M | $34M | $34M | $33M | |
| Operating Income | $8M | $17M | $7M | $4M | $-3M | $2M | $-13M | $-8M | $-14M | $-10M | $-5M | $-16M | $-13M | $-15M | $-19M | $-19M | |
| Interest Expense | · | · | · | · | · | · | · | · | $7M | · | $7M | $7M | $6M | · | $4M | $3M | |
| Other Non-op | $-6M | $-6M | $-6M | $-6M | $-6M | $-7M | $-6M | $-6M | $-4M | $-4M | $-8M | $-5M | $-4M | $2M | $-3M | $-8M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-3M | $749.0K | $307.0K | $-236.0K | $-338.0K | $-675.0K | $0 | $-338.0K | $-339.0K | $-339.0K | |
| Net Income | $2M | $11M | $621.0K | $-2M | $-9M | $-5M | $-16M | $-15M | $-19M | $-13M | $-12M | $-20M | $-17M | $-13M | $-22M | $-26M | |
| EPS (Basic) | $0.01 | $0.07 | $0.00 | $-0.01 | $-0.06 | $-0.02 | $-0.11 | $-0.10 | $-0.14 | $-0.10 | $-0.09 | $-0.14 | $-0.12 | $-0.10 | $-0.16 | $-0.19 | |
| EPS (Diluted) | $0.01 | $0.07 | $0.00 | $-0.01 | $-0.06 | $-0.02 | $-0.11 | $-0.10 | $-0.14 | $-0.10 | $-0.09 | $-0.14 | $-0.12 | $-0.10 | $-0.16 | $-0.19 | |
| Shares (Basic) | 170,523,208 | -315,130,082 | 163,649,932 | 159,459,413 | 152,445,935 | -291,080,521 | 148,993,823 | 148,345,549 | 140,513,907 | -274,865,560 | 138,059,781 | 137,338,071 | 137,142,565 | -270,885,790 | 135,951,761 | 135,529,968 | |
| Shares (Diluted) | 177,631,154 | -316,779,935 | 177,617,307 | 159,459,413 | 152,445,935 | -291,080,521 | 148,993,823 | 148,345,549 | 140,513,907 | -274,865,560 | 138,059,781 | 137,338,071 | 137,142,565 | -270,885,790 | 135,951,761 | 135,529,968 | |
| EBITDA | $8M | · | $7M | $4M | $-3M | · | $-13M | $-8M | $-14M | · | $-5M | $-16M | $-13M | · | $-19M | $-19M |
Stato Patrimoniale 29
| Metrica | Tendenza | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $112M | $111M | $92M | $59M | $58M | $72M | $59M | $58M | · | $67M | $46M | · | · | · | $84M | $95M | |
| Short-term Investments | · | · | · | · | · | · | $10M | $20M | · | · | $20M | · | · | · | $9M | $16M | |
| Receivables | $56M | $51M | $54M | $53M | $46M | $40M | $41M | $42M | · | · | $46M | · | · | · | $28M | $26M | |
| Inventory | $74M | $69M | $67M | $67M | $53M | $48M | $45M | $43M | · | · | $38M | · | · | · | $20M | $18M | |
| Prepaid Expense | $9M | $10M | $11M | $6M | $6M | $7M | $7M | $7M | · | · | $8M | · | · | · | $8M | $6M | |
| Current Assets | $252M | $240M | $224M | $186M | $163M | $168M | $163M | $170M | · | · | $158M | · | · | · | $149M | $161M | |
| PP&E (Net) | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | · | · | $6M | · | · | · | $6M | $6M | |
| PP&E (Gross) | $14M | $13M | $13M | $13M | $13M | $13M | $13M | $12M | · | · | $12M | · | · | · | $11M | $11M | |
| Accum. Depreciation | $9M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | · | · | $6M | · | · | · | $5M | $5M | |
| Goodwill | $23M | $23M | $23M | $23M | $23M | $23M | $23M | $23M | · | · | $23M | · | · | · | $23M | $23M | |
| Intangibles | $85M | $88M | $91M | $94M | $96M | $99M | $102M | $104M | · | · | $112M | · | · | · | $123M | $126M | |
| Other Non-current Assets | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | · | $5M | · | · | · | $2M | $2M | |
| Total Assets | $392M | $384M | $370M | $335M | $315M | $323M | $321M | $332M | · | · | $328M | · | · | · | $303M | $319M | |
| Accounts Payable | $11M | $3M | $7M | $9M | $6M | $2M | $7M | $6M | · | · | $12M | · | · | · | $4M | $7M | |
| Accrued Liabilities | $32M | $33M | $30M | $25M | $20M | $28M | $24M | $23M | · | · | $19M | · | · | · | $38M | $37M | |
| Current Liabilities | $119M | $110M | $116M | $95M | $95M | $100M | $91M | $75M | · | · | $87M | · | · | · | $69M | $65M | |
| Capital Leases | $31M | $32M | $32M | $32M | $33M | $33M | $34M | $34M | · | · | $35M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | $0 | $3M | · | · | $3M | · | · | · | $4M | $4M | |
| Other Non-current Liabilities | $8M | $8M | $3M | $8M | $5M | $2M | $9M | $8M | · | · | $4M | · | · | · | $311.0K | $848.0K | |
| Total Liabilities | $379M | $370M | $371M | $354M | $351M | $353M | $349M | $351M | · | · | $324M | · | · | · | $248M | $245M | |
| Long-term Debt | $221M | $220M | $219M | $219M | $230M | $232M | $216M | $230M | · | · | $190M | · | · | · | $139M | $138M | |
| Total Debt | · | · | $219M | $219M | $230M | · | $15M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $18.0K | $17.0K | $17.0K | $16.0K | $16.0K | $15.0K | $15.0K | $15.0K | · | · | $14.0K | · | · | · | $14.0K | $14.0K | |
| Paid-in Capital | $682M | $685M | $682M | $664M | $646M | $642M | $638M | $632M | · | · | $608M | · | · | · | $597M | $594M | |
| Retained Earnings | $-669M | $-671M | $-682M | $-683M | $-681M | $-672M | $-667M | $-651M | · | · | $-604M | · | · | · | $-542M | $-520M | |
| AOCI | $-24.0K | $-25.0K | $-25.0K | $-24.0K | $-25.0K | $-25.0K | $-16.0K | $-31.0K | · | · | $-50.0K | · | · | · | $-37.0K | $-52.0K | |
| Stockholders' Equity | $13M | $14M | $-861.0K | $-19M | $-35M | $-30M | $-28M | $-19M | · | $-7M | $4M | · | · | $45M | $55M | $74M | |
| Liabilities + Equity | $392M | $384M | $370M | $335M | $315M | $323M | $321M | $332M | · | · | $328M | · | · | · | $303M | $319M | |
| Shares Outstanding | 172,558,783 | 166,215,410 | 165,528,253 | 161,224,762 | 156,014,050 | 149,429,410 | 149,003,934 | 148,936,727 | · | · | 138,067,806 | · | · | · | 135,961,552 | · |
Flusso di cassa 13
| Metrica | Tendenza | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $337.0K | $335.0K | $338.0K | $325.0K | $315.0K | $313.0K | $307.0K | $281.0K | $326.0K | $346.0K | $391.0K | $386.0K | $364.0K | $366.0K | $360.0K | $352.0K | |
| Stock-based Comp | $4M | $5M | $8M | $5M | $4M | $4M | $7M | $4M | $4M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | $-3M | $749.0K | $307.0K | $-1M | $675.0K | $-675.0K | $0 | · | · | · | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-cash | $3M | · | · | · | $-6M | · | · | · | $-6M | · | · | · | $-12M | · | · | · | |
| Operating Cash Flow | $10M | $20M | $18M | $182.0K | $-10M | $2M | $-8M | $-10M | $-20M | $7M | $-15M | $-14M | $-26M | $-16M | $-18M | $-21M | |
| Investing Cash Flow | $-325.0K | $-333.0K | $-71.0K | $-279.0K | $-13.0K | $10M | $10M | $5M | $-20M | $15M | $15M | $8M | $-44M | $9M | $7M | $12M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $49M | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $-9M | $-266.0K | $14M | $942.0K | $-3M | $398.0K | $-83.0K | $659.0K | $35M | $-1M | $-72.0K | $556.0K | $-863.0K | $49M | $-187.0K | $310.0K | |
| Net Change in Cash | $708.0K | $19M | $32M | $845.0K | $-13M | $12M | $2M | $-5M | $-5M | $21M | $-27.0K | $-5M | $-71M | $42M | $-11M | $-8M |
Redditività 5
| Metrica | Tendenza | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 9.5% | · | 9.0% | 6.3% | -5.1% | · | -23.8% | -17.0% | -35.0% | · | -10.2% | -42.0% | -40.0% | · | -63.2% | -74.8% | |
| Net Margin | 2.7% | · | 0.83% | -2.7% | -15.3% | · | -29.0% | -31.2% | -46.7% | · | -25.2% | -52.2% | -50.7% | · | -73.4% | -103.5% | |
| EBITDA Margin | 9.9% | · | 9.0% | 6.3% | -4.6% | · | -23.8% | -17.0% | -34.2% | · | -10.2% | -42.0% | -38.9% | · | -63.2% | -74.8% | |
| ROA | · | · | 0.18% | -0.58% | -2.8% | · | -4.9% | -4.6% | · | · | -3.9% | · | · | · | -10.1% | -16.4% | |
| ROE | · | · | -4.3% | 10.0% | -30.1% | · | 128.7% | -54.9% | · | · | -41.4% | · | · | · | -83.0% | -70.8% |
Liquidità e Solvibilità 5
| Metrica | Tendenza | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 1.9 | 1.9 | 1.7 | · | 1.8 | 2.3 | · | · | 1.8 | · | · | · | 2.2 | 2.5 | |
| Quick Ratio | · | · | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.6 | · | · | 1.3 | · | · | · | 1.8 | 2.1 | |
| Debt / Equity | · | · | -254.9 | -11.3 | -6.5 | · | -0.5 | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | -254.9 | -11.3 | -6.2 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -2.0 | · | -0.7 | -2.4 | -2.1 | · | -4.7 | -5.5 |
Efficienza 2
| Metrica | Tendenza | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | · | · | 0.2 | · | · | · | 0.1 | 0.2 | |
| Receivables Turnover | · | · | 1.6 | 1.5 | 1.7 | · | 1.2 | 1.4 | · | · | 1.3 | · | · | · | 2.2 | 2.0 |
Valutazione (TTM) 11
| Metrica | Tendenza | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $289M | · | $260M | $234M | $203M | · | $191M | $175M | $160M | · | $149M | $126M | $110M | · | $88M | $67M | |
| Net Income TTM | $-8M | · | $-26M | $-42M | $-59M | · | $-62M | $-66M | $-68M | · | $-71M | $-85M | $-99M | · | $-108M | $-113M | |
| Market Cap | · | · | $1.35B | $753M | $857M | · | $425M | $335M | · | · | $257M | · | · | · | $212M | · | |
| Enterprise Value | · | · | $1.48B | $912M | $1.03B | · | $370M | · | · | · | · | · | · | · | · | · | |
| P/E | -96.7 | · | -45.2 | -16.7 | -13.4 | · | -6.5 | -4.8 | -4.5 | · | -3.6 | -4.3 | -2.3 | · | -1.6 | -1.2 | |
| P/S | · | · | 5.2 | 3.2 | 4.2 | · | 2.2 | 1.9 | · | · | 1.7 | · | · | · | 2.4 | · | |
| P/B | · | · | -1564.9 | -39.0 | -24.4 | · | -15.0 | -17.4 | · | · | 66.4 | · | · | · | 3.9 | · | |
| P / Cash Flow | · | · | · | · | -85.4 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | · | · | 219.2 | 203.5 | -370.4 | · | -28.7 | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | 5.7 | 3.9 | 5.1 | · | 1.9 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.0% | · | -2.2% | -6.0% | -7.5% | · | -15.4% | -20.9% | -22.2% | · | -27.4% | -23.3% | -44.2% | · | -63.5% | -80.5% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2024-03-31 | 2023-12-31 | 2023-06-30 | |
|---|---|---|---|---|---|
| Ricavi | $292M | $203M | — | $164M | — |
| Margine Operativo % | 8.5% | -16.6% | — | -26.9% | — |
| Utile netto | $554.0K | $-55M | — | $-62M | — |
| EPS Diluito | $0.00 | $-0.37 | — | $-0.45 | — |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2024-03-31 | 2023-12-31 | 2023-06-30 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 16.1 | -7.8 | — | — | — |
| Rapporto corrente | 2.2 | 1.7 | — | 1.6 | — |
| Quick Ratio | 1.5 | 1.1 | — | 1.2 | — |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.